Glutathione Resin Market Estimated to Cross US$ 877.46 Mn by 2030

The global Glutathione Resin market size was reached at USD 450.60 million in 2020 and is projected to surpass US$ 877.46 million by 2030, expanding growth at a CAGR of 10.4% from 2021 to 2030. 

Download Exclusive Sample of Report@  https://www.visionresearchreports.com/report/sample/38433

Growth Factors

The market is majorly driven by the rising product demand on account of the rapid expansion of pharmaceutical industries and vaccine production.

Glutathione is widely used across numerous applications, such as cosmetics and owing to its beneficial properties. The product is one of the majorly used skin whitening agents in the cosmetic industry. Nowadays, skin whitening agents, either intravenous, oral, or topical, are widely available in the markets. Thus, the demand for glutathione is expected to increase over the forecast period, specifically in the cosmetic industry.

The growing investments for the development of structure-based drugs and technological advancements by both public and private research organizations are driving the demand for protein purification, in turn, making the protein purification application the dominant application segment and driving the product demand. 

Report Highlights

The protein purification application segment dominated the market with a revenue share of over 51% in 2020. This high share was attributed to the increased demand for protein extraction from complex mixtures and increased research in biotechnological & pharmaceutical fields. Companies have developed protein purification technologies to develop COVID-19 vaccines.

Asia Pacific accounted for the highest revenue share of more than 51% in 2020 and is anticipated to grow at the fastest CAGR of more than 10% over the forecast period. This share is attributed to the growing government support for domestic manufacturing, which is likely to boost the production levels and reduce the dependence on imports in the Asia Pacific region, thereby offering lucrative opportunities to global manufacturers.

Key Players

  • Merck kGaA
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • Cytiva
  • Takara Bio, Inc.
  • Mitsubishi Corporation Life Sciences Ltd.
Report Coverage Details
Market Size US$ 877.46 million by 2030
Growth Rate CAGR of 10.4% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Application
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Merck KGaA; Thermo Fisher Scientific Inc.; Cytiva; Bio-Rad Laboratories, Inc.; Takara Bio Inc.; Mitsubishi Corporation Life Sciences Ltd.

Market Segmentation

  • Application
    • Protein Purification
    • Immunoprecipitation (IP)
    • Research
    • Others
  • Regional
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
    • Central & South America
      • Brazil
      • Argentina
    • Middle East & Africa
      • Saudi Arabia
      • South Africa

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38433

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Glutathione Resin Market, By Application

7.1.  Glutathione Resin Market, by Application, 2020-2030

7.1.1.    Protein Purification

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Immunoprecipitation (IP)

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Research

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    Others

7.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Glutathione Resin Market, Regional Estimates and Trend Forecast

8.1.  North America

8.1.1.    Market Revenue and Forecast, by Application (2016-2030)

8.1.2.    U.S.

8.1.3.    Rest of North America

8.1.3.1.        Market Revenue and Forecast, by Application (2016-2030)

8.2.  Europe

8.2.1.    Market Revenue and Forecast, by Application (2016-2030)

8.2.2.    UK

8.2.2.1.        Market Revenue and Forecast, by Application (2016-2030)

8.2.3.    France

8.2.3.1.        Market Revenue and Forecast, by Application (2016-2030)

8.2.4.    Rest of Europe

8.2.4.1.        Market Revenue and Forecast, by Application (2016-2030)

8.3.  APAC

8.3.1.    Market Revenue and Forecast, by Application (2016-2030)

8.3.2.    India

8.3.2.1.        Market Revenue and Forecast, by Application (2016-2030)

8.3.3.    China

8.3.3.1.        Market Revenue and Forecast, by Application (2016-2030)

8.3.4.    Japan

8.3.4.1.        Market Revenue and Forecast, by Application (2016-2030)

8.3.5.    Rest of APAC

8.3.5.1.        Market Revenue and Forecast, by Application (2016-2030)

8.4.  MEA

8.4.1.    Market Revenue and Forecast, by Application (2016-2030)

8.4.2.    GCC

8.4.2.1.        Market Revenue and Forecast, by Application (2016-2030)

8.4.3.    North Africa

8.4.3.1.        Market Revenue and Forecast, by Application (2016-2030)

8.4.4.    South Africa

8.4.4.1.        Market Revenue and Forecast, by Application (2016-2030)

8.4.5.    Rest of MEA

8.4.5.1.        Market Revenue and Forecast, by Application (2016-2030)

8.5.  Latin America

8.5.1.    Market Revenue and Forecast, by Application (2016-2030)

8.5.2.    Brazil

8.5.2.1.        Market Revenue and Forecast, by Application (2016-2030)

8.5.3.    Rest of LATAM

8.5.3.1.        Market Revenue and Forecast, by Application (2016-2030)

Chapter 9.    Company Profiles

9.1.  Merck kGaA

9.1.1.    Company Overview

9.1.2.    Product Offerings

9.1.3.    Financial Performance

9.1.4.    Recent Initiatives

9.2.  Bio-Rad Laboratories, Inc.

9.2.1.    Company Overview

9.2.2.    Product Offerings

9.2.3.    Financial Performance

9.2.4.    Recent Initiatives

9.3.  Thermo Fisher Scientific, Inc.

9.3.1.    Company Overview

9.3.2.    Product Offerings

9.3.3.    Financial Performance

9.3.4.    Recent Initiatives

9.4.  Cytiva

9.4.1.    Company Overview

9.4.2.    Product Offerings

9.4.3.    Financial Performance

9.4.4.    Recent Initiatives

9.5.  Takara Bio, Inc.

9.5.1.    Company Overview

9.5.2.    Product Offerings

9.5.3.    Financial Performance

9.5.4.    Recent Initiatives

9.6.  Mitsubishi Corporation Life Sciences Ltd.

9.6.1.    Company Overview

9.6.2.    Product Offerings

9.6.3.    Financial Performance

9.6.4.    Recent Initiatives

Chapter 10.  Research Methodology

10.1.              Primary Research

10.2.              Secondary Research

10.3.              Assumptions

Chapter 11.  Appendix

11.1.              About Us

11.2.              Glossary of Terms

Buy this Research Report study@https://www.visionresearchreports.com/report/cart/38433

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com